Efficacy of Gemtuzumab Ozogamycin for Patients Presenting an Acute Myeloid Leukemia (AML) With Intermediate Risk

NCT00860639 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

327

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: gemtuzumab ozogamycin

Sponsor

Nantes University Hospital

Collaborators

[object Object]
[object Object]